833 Chestnut Street, Suite 700
Philadelphia, PA 19107
Phone: 215-503-3000
Fax: 215-503-4099
Diabetes is the leading cause of kidney disease in the United States, and it continues to increase every year. The Center
for Diabetic Kidney Disease at Thomas Jefferson University was initiated in 1996 by Dr. Kumar Sharma to provide a resource
for patients and primary care providers through education and providing treatment approaches with the goal of optimizing the
care of all diabetic patients. At the Center for Diabetic Kidney Disease there is a commitment to provide patients with the
very best care available and to understand diabetic kidney disease at the basic science level. Specialized physicians and
nurses, research personnel, a dietician, and other support staff are committed to providing quality care to patients with
diabetes and kidney involvement. This approach, combined with the latest breakthroughs in research, will help prevent the
steady increase in the number of patients with progression of diabetic kidney disease.
It is the goal of the staff of the Center for Diabetic Kidney Disease at TJU that the patient will become a willing participant
in his or her own care. The multi-disciplinary care team realizes that controlling diabetes can be very difficult, confusing
and at times even overwhelming for the patient. Through patient education and physician interaction from the time that the
patient is first evaluated, the staff of the Center for Diabetic Kidney Disease provides the care and support that patients
need to understand and participate in their own care.
New Clinical Trial for Patients with Diabetes and Kidney Involvement
Dr. Kumar Sharma and Dr. Tracy McGowan are conducting a new NIH-funded clinical trial at the Center for Diabetic Kidney Disease
at TJU. The purpose of this study is to test the effectiveness of a medication called pirfenidone in the prevention of scarring
in the kidneys of diabetic patients. To participate in the trial of this medication, subjects must be Diabetic and have high
blood pressure. For more information, visit NIH Clinical Trial or contact the Center for Diabetic Kidney Disease at Thomas Jefferson University 215-503-3000.
Jefferson Scientists Uncover Potential Trigger of Diabetic Kidney Disease
(Published 2-21-2005) Scientists at Jefferson Medical College and Mount Sinai School of Medicine have identified a protein
that plays a leading part in triggering kidney disease in diabetic patients, a condition known as diabetic nephropathy and
the leading cause of kidney failure worldwide.
Links:
